Biosimilars: Barriers and Opportunities to Market Access in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.04.625
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Barriers to Oncology Biosimilars Uptake in the United States

Oncologist
Cancer ResearchMedicineOncology
2018English

Improving College Access in the United States: Barriers and Policy Responses

2015English

Php129 - Challenges and Opportunities in the Biologicals-Biosimilars Market: Sustainability and Market Differentiation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Geographic Access to Hospice in the United States

Journal of Palliative Medicine
MedicineAnesthesiologyPain MedicineNursing
2010English

Access to Pediatric Trauma Care in the United States

Archives of Pediatrics & Adolescent Medicine
2009English

Access Denied! Contrasting Data Access in the United States and Ireland

Proceedings on Privacy Enhancing Technologies
2016English

Abortion in the United States: Incidence and Access to Services, 2005

Perspectives on Sexual and Reproductive Health
SociologyPolitical ScienceGynecologyPublic HealthEnvironmentalObstetricsOccupational Health
2008English

Geographic Access to Acute Stroke Care in the United States

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2014English

Differences in Referral Access to Care Between Gastrointestinal Subspecialty Patients: Barriers and Opportunities

Health Equity
Health Information ManagementEnvironmentalPublic HealthHealth PolicyHealthOccupational Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy